EMEA-001665-PIP01-14-M03

Key facts

Active substance
Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human βA-T87Q-globin gene
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0020/2020
PIP number
EMEA-001665-PIP01-14-M03
Pharmaceutical form(s)
Dispersion for infusion
Condition(s) / indication(s)
Treatment of β-thalassaemia
Route(s) of administration
Intravenous use
Contact for public enquiries
bluebird bio (Netherlands) B.V.

E-mail: patient.advocacy@bluebirdbio.com
Tel. +1 3394999300

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating